Cargando…

Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper

INTRODUCTION: People of Ashkenazi Jewish (AJ) ancestry are more likely than unselected populations to have a BRCA1/2 pathogenic variant, which cause a significantly increased risk of breast, ovarian and prostate cancer. Three specific BRCA1/2 pathogenic variants, referred to as BRCA-Jewish founder m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cousens, Nicole E, Tiller, Jane, Meiser, Bettina, Barlow-Stewart, Kristine, Rowley, Simone, Ko, Yi-An, Mahale, Sakshi, Campbell, Ian G, Kaur, Rajneesh, Bankier, Agnes, Burnett, Leslie, Jacobs, Chris, James, Paul A, Trainer, Alison, Neil, Suzanne, Delatycki, Martin B, Andrews, Lesley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237737/ https://www.ncbi.nlm.nih.gov/pubmed/34172541 http://dx.doi.org/10.1136/bmjopen-2020-041186

Ejemplares similares

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
por: Vazina, A, et al.
Publicado: (2000)

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
por: Tennen, Ruth I., et al.
Publicado: (2020)

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
por: Solano, Angela R., et al.
Publicado: (2018)

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
por: Hamel, Nancy, et al.
Publicado: (2003)

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)
por: Apicella, Carmel, et al.
Publicado: (2003)

Counting the Founders: The Matrilineal Genetic Ancestry of the Jewish Diaspora
por: Behar, Doron M., et al.
Publicado: (2008)

The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel
por: Figer, A, et al.
Publicado: (2001)

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations
por: Greenwood, Celia MT, et al.
Publicado: (2010)

Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients
por: Díez, O, et al.
Publicado: (1999)

A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services
por: Peacock, S, et al.
Publicado: (2006)

Tongue Ties or Fragments Transformed: Making Sense of Similarities and Differences between the Five Largest English-Speaking Jewish Communities
por: Bankier-Karp, Adina L.
Publicado: (2023)

Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations
por: Cox, Devin M., et al.
Publicado: (2018)

Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial
por: Manchanda, Ranjit, et al.
Publicado: (2014)

Exploration of decision-making regarding the transfer of mosaic embryos following preimplantation genetic testing: a qualitative study
por: Cheng, Lin, et al.
Publicado: (2022)

Founder BRCA1 mutations in Nepalese population
por: Mehta, Anurag, et al.
Publicado: (2022)

Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice
por: Meiser, Bettina, et al.
Publicado: (2021)

Study protocol: the Australian genetics and life insurance moratorium—monitoring the effectiveness and response (A-GLIMMER) project
por: Tiller, Jane, et al.
Publicado: (2021)

Health professionals’ views and experiences of the Australian moratorium on genetic testing and life insurance: A qualitative study
por: Dowling, Grace, et al.
Publicado: (2022)

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001)

Identification of a founder BRCA2 mutation in Sardinia
por: Pisano, M, et al.
Publicado: (2000)

Evidence of a founder BRCA1 mutation in Scotland
por: Liede, A, et al.
Publicado: (2000)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
por: Maksimenko, J., et al.
Publicado: (2018)

The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers
por: Grossman, Sharon Galper
Publicado: (2015)

Evaluating the model of offering expanded genetic carrier screening to high school students within the Sydney Jewish community
por: Barlow-Stewart, Kristine, et al.
Publicado: (2021)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
por: Manchanda, Ranjit, et al.
Publicado: (2014)

BRCA1 founder mutations compared to ovarian cancer in Belarus
por: Savanevich, Alena, et al.
Publicado: (2014)

A Founder Mutation of the BRCA1-Gene in Western Sweden
por: Einbeigi, Zakaria, et al.
Publicado: (1999)

Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
por: Caleca, Laura, et al.
Publicado: (2014)

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
por: Kluz, Tomasz, et al.
Publicado: (2018)

Genetic discrimination by Australian insurance companies: a survey of consumer experiences
por: Tiller, Jane, et al.
Publicado: (2019)

Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study
por: Yanes, Tatiane, et al.
Publicado: (2017)

The Jewish anthology
por: Fleg, Edmond 1874-1963
Publicado: (1925)

The Icelandic founder mutation BRCA2 999del5: analysis of expression
por: Mikaelsdottir, Evgenia K, et al.
Publicado: (2004)

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
por: Behl, Supriya, et al.
Publicado: (2020)

Jewish song : from Jewish life, no. 3 : cello solo with piano accompaniment /
por: Bloch, Ernest, 1880-1959
Publicado: (1925)

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
por: Lehrer, S., et al.
Publicado: (1998)

BRCA1 4153delA founder mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2006)

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile
por: Alvarez, Carolina, et al.
Publicado: (2017)

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects
por: Peixoto, Ana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4kv405jqfj9vr7c22heafmp5lk